Over the past decade and a half, GiveWell has become one of the most influential voices in evidence-based philanthropy, directing hundreds of millions of dollars each year to high-impact charities focused primarily on global health and poverty reduction. As it has grown, GiveWell has also faced serious critiques and has repeatedly refined its methods in response. Understanding that evolution can help any donor think more clearly about how to give.
This article explores how GiveWell’s approach has changed, what it learned from evaluating specific interventions, the major philosophical critiques it faces, and what all of this implies for individuals and institutions that want to make their donations count.
From Small Research Project to Major Philanthropic Gatekeeper
GiveWell was founded in 2007 to answer a deceptively simple question: where can a donor do the most good with the next dollar? In its early years, the organisation focused on a small set of global health and anti-poverty charities with unusually strong evidence of impact. Over time, both its influence and research agenda have expanded dramatically.
- Money moved: GiveWell now influences or directly allocates around hundreds of millions of dollars per year to recommended organisations, up from only a few million in its early days.
- Research depth: Its research team has grown, allowing more complex modelling, field engagement, and scrutiny of program implementation.
- Wider portfolio: The organisation has moved from a small, stable list of “top charities” to a broader set of grants across global health, nutrition, and related areas.
This growth forced GiveWell to confront questions that are relevant for any serious donor: how to compare very different kinds of impact, how to handle uncertainty, and how to respond when new data or critiques undermine earlier conclusions.
How GiveWell Tries to Measure Impact
GiveWell’s core goal is to identify opportunities where a marginal dollar does far more good than typical charitable spending. To do that, it builds explicit models of impact that combine epidemiological data, program evidence, cost information, and moral assumptions.
Core outcome metrics
Most of GiveWell’s charity recommendations are in global health and development, so its metrics centre on health and income effects.
- Lives saved: Estimated number of deaths averted, often among children under five, typically via proven interventions like vaccines or malaria prevention.
- Income gains: Measures such as household incomes doubled, comparing interventions to cash transfers.
- Health-adjusted life years: Use of quality-adjusted life years (QALYs) or similar measures to combine quantity and quality of life into a single scale.
These metrics are common in global health and health economics more broadly, including in World Health Organization (WHO) and national health-technology assessments, because they permit comparison across very different medical interventions.
“Moral weights” and value judgements
To compare lives saved to income gains or reductions in illness, GiveWell must apply moral weights—numerical assumptions about how valuable different outcomes are relative to one another. For example:
- How many years of doubled income are worth as much as preventing the death of a child?
- Is preventing severe chronic pain more or less important than modestly extending life?
GiveWell acknowledges that this is one of the least mature and most contestable parts of its work. Nonetheless, making the assumptions explicit has advantages:
- Transparency: Donors can see the value judgements baked into recommendations.
- Debatability: Philosophers, researchers, and the public can challenge or refine those numbers.
- Comparability: Programs can be ranked by expected value per dollar, despite measuring different outcomes.
Lessons from Analysing Specific Interventions
In recent years, GiveWell expanded beyond its originally recommended top charities (such as malaria prevention and deworming) to evaluate a wider array of programs: water chlorination, maternal and newborn care, treatment of severe childhood malnutrition, surgical care for conditions like clubfoot, and more. These case studies have yielded general lessons for charity evaluation.
| Program Type | Main Goal | Illustrative Lesson |
|---|---|---|
| Safe drinking water | Reduce diarrhoeal disease & child mortality | Implementation and behavioural adherence can dominate theoretical efficacy. |
| Maternal & newborn support | Help premature & low-birth-weight infants survive | Simple, low-tech practices may outperform more complex medical setups in low-resource settings. |
| Technical assistance to health systems | Improve quality of care at scale | Expert advice can be highly leveraged but is harder to measure and attribute. |
| Nutritional supplementation | Prevent deficiency-related blindness & mortality | Benefits can be large but strongly context-dependent on baseline deficiency rates. |
Lesson 1: Small design choices can change cost-effectiveness dramatically
For interventions like chlorine dispensers for safe water, field implementation details—such as how close the dispenser is to households, whether local promoters sustain usage norms, and how often supplies are replenished—can make the difference between outstanding and mediocre impact per dollar.
As GiveWell gathered more data, it revised its view of some water programs, upgrading their cost-effectiveness after evidence showed larger-than-expected mortality reductions when implemented at scale. This illustrates a broader point: big updates often come from better real-world data, not just better theory.
Lesson 2: Low-tech care can sometimes beat high-tech care
In neonatal care, a global body of evidence suggests that straightforward interventions such as immediate skin-to-skin contact, thermal regulation, and support for breastfeeding can significantly reduce mortality for premature or low-birth-weight infants in low-resource settings. This underpins approaches like kangaroo mother care, which emphasise proximity and basic care rather than intensive technological equipment.
Evaluating such programs forced GiveWell to consider:
- Whether existing hospital infrastructure can reliably support high-tech interventions.
- How staff training, cultural norms, and family involvement shape feasibility.
- The extent to which results from clinical trials generalise to routine practice in poorer settings.
Lesson 3: Technical advice can be powerful but hard to quantify
Some GiveWell-supported projects focus on technical assistance—for example, helping governments or hospitals adopt best practices in maternal care, diagnosis, or treatment protocols. Similar approaches are seen in WHO and World Bank programs that aim to improve health systems rather than fund a single commodity.
These efforts can change the behaviour of entire systems, affecting many patients for years. However, quantifying their impact is challenging because:
- Outcomes may be influenced by many concurrent reforms.
- Improvements may roll out unevenly across regions.
- Randomised controlled trials are often impractical or politically infeasible at scale.
GiveWell’s growing engagement with such programs reflects a trade-off: less certain estimates, but potentially more leveraged impact.
Lesson 4: Context sensitivity in nutrition and supplementation
Nutritional interventions like vitamin A supplementation have been a cornerstone of global health policy, with large trials showing substantial reductions in child mortality where deficiency is common. As more recent data emerge, researchers and organisations—including GiveWell—have needed to update their assumptions about:
- How deficiency prevalence has changed over time in different regions.
- Whether older trials are representative of current conditions.
- How side effects and implementation challenges alter real-world effectiveness.
The broader lesson is that historic evidence is not automatically a guide to current cost-effectiveness; it must be reinterpreted in light of changing baselines and new data.
Two Big-Picture Critiques of GiveWell’s Approach
As GiveWell’s influence has grown, so has scrutiny of its method and priorities. Two especially important critiques relate to how it measures impact and how it chooses focus areas.
Critique 1: Use subjective wellbeing as the master metric
One school of thought, represented by researchers at organisations such as the Happier Lives Institute, argues that the best outcome measure is subjective wellbeing—how people actually feel about their lives—and that all interventions should ultimately be compared on this basis.
Instead of starting from lives saved or income changes, this approach emphasises self-reported life satisfaction or affect, often aggregated into a measure like the wellbeing-adjusted life year (WELLBY). The arguments include:
- Philosophical clarity: If our goal is to make lives go better from the perspective of the people living them, then happiness and suffering are the natural units for comparison.
- Cross-domain comparability: WELLBYs can directly compare mental health therapy to cash transfers to physical health interventions.
- Different priorities: Some analyses using wellbeing data give relatively higher weight to interventions like mental health treatment, which may improve day-to-day experience more than they extend life or raise income.
GiveWell already incorporates wellbeing considerations indirectly through its moral weights, but it still anchors most models in health and income outcomes rather than directly in subjective wellbeing scales. The debate here is not about whether wellbeing matters, but about which measurement strategy should sit at the centre of evaluation.
Critique 2: Economic growth should dominate the agenda
A second critique contends that the primary driver of long-run poverty reduction is broad-based economic growth, not specific health or transfer programs. Historical cases such as China’s and South Korea’s rapid growth are often cited, where hundreds of millions escaped extreme poverty through structural economic transformation, trade, and industrialisation rather than through targeted health campaigns alone.
According to this view:
- Policies and institutions that raise long-run productivity may dwarf the impact of even excellent health programs.
- Philanthropy might do more good by supporting research, policy advocacy, or institution-building that enhances growth.
- Narrow focus on easily measured health outcomes could systematically underweight harder-to-measure but more transformative reforms.
GiveWell has generally remained focused on relatively concrete, measurable interventions, partly because the evidence base and causal pathways for growth-promoting reforms are complex and uncertain. However, it recognises this critique as a potential reason why its portfolio might miss some of the best opportunities.
How GiveWell Responds to These Critiques
GiveWell’s response to both critiques is nuanced rather than purely defensive. Its evolving practice reflects a combination of continuity and change.
On subjective wellbeing
In response to wellbeing-focused critiques, GiveWell has:
- Engaged with wellbeing research: Reviewing studies that connect income and health improvements to life satisfaction or happiness scores.
- Refined moral weights: Adjusting how it values health vs. income in light of new evidence about their impact on self-reported wellbeing.
- Maintained plural metrics: Retaining health and income as primary building blocks, partly due to practical issues like limited high-quality wellbeing data for many interventions.
This hybrid stance accepts the importance of wellbeing while arguing that, for now, health and income remain more robustly measured in many low-income settings.
On economic growth
Regarding the growth-focused critique, GiveWell generally:
- Acknowledges the importance of growth: Empirically, rising GDP per capita is strongly associated with long-term reductions in extreme poverty and child mortality.
- Emphasises tractability & attribution: It focuses on areas where a donor’s marginal contribution can be more clearly linked to outcomes—such as purchasing bednets or funding a vaccination campaign—compared to high-level macroeconomic reforms.
- Remains open to change: As the evidence base for specific growth-promoting philanthropic strategies improves, GiveWell may further expand into that domain.
The tension here is between scale of potential impact and confidence in causal impact per dollar. Growth-oriented strategies may be larger in principle but harder to pin down empirically.
Institutional Strengths, Weaknesses, and Course Corrections
Across these debates, GiveWell’s institutional culture plays a central role. Two traits stand out: a strong commitment to rigour and a cautious, sometimes slow, decision-making style.
- Rigour as a strength: Extensive modelling, critical internal review, and willingness to publish reasoning make it more likely that errors will eventually be caught and corrected.
- Rigour as a bottleneck: High standards can slow down grant-making or push GiveWell away from areas where evidence is thinner but potential upside is large.
Over time, GiveWell has increasingly:
- Expanded into somewhat less certain but higher-upside opportunities, such as broader policy or technical assistance work.
- Consulted external experts more systematically to avoid overly narrow modelling assumptions.
- Updated or reversed earlier positions when new evidence or arguments showed that previous cost-effectiveness estimates were off.
For donors, the takeaway is that good giving is a process, not a one-time calculation. The best opportunities can shift as more data become available or as the world changes.
Practical Takeaways for Donors
Whether or not one fully agrees with GiveWell’s framework, several practical lessons from its work can guide more thoughtful giving.
- Prioritise transparency: Favour organisations that share their data, methods, and limitations openly.
- Ask “compared to what?”: Evaluate opportunities relative to realistic alternatives, not in isolation.
- Beware stories without numbers: Compelling anecdotes are not enough; look for evidence about average outcomes.
- Embrace uncertainty, but quantify it: It is better to have rough probability-based estimates than to rely purely on intuition.
- Be willing to update: As new evidence or critiques emerge, be ready to shift donations to higher-impact options.
Even small donors can apply these principles: by using independent evaluators like GiveWell, by supporting organisations with strong monitoring and evaluation, and by treating donations as an ongoing learning project.
Frequently Asked Questions (FAQs)
Q1: Does GiveWell only care about saving lives, not improving them?
No. While many GiveWell recommendations focus on preventing deaths, its models also value improvements in health and income, using moral weights to compare these outcomes. Debates with wellbeing-focused researchers are about how to measure and aggregate benefits, not whether quality of life matters.
Q2: Why doesn’t GiveWell focus more on mental health?
Subjective wellbeing research suggests some mental health interventions may be highly cost-effective, but the evidence base in low-income settings is still limited, and program models are less standardised than, say, vaccine delivery. As data and scalable models improve, evaluators like GiveWell may increase attention to mental health interventions.
Q3: Are randomised controlled trials the only evidence GiveWell uses?
No. Randomised trials are important where available, especially in global health, but GiveWell also relies on observational data, implementation reports, cost and coverage statistics, and expert judgement—particularly for system-level or policy-oriented programs where experiments are not feasible.
Q4: Can very small donations really make a difference if large funders follow GiveWell?
Yes. Many high-impact programs are funding constrained rather than idea constrained. When donors of any size collectively direct more resources to the most effective opportunities, implementers can expand coverage, reach new regions, and maintain quality.Moreover, small donors help sustain the independence and diversity of funding sources.
Q5: How often should donors revisit where they give?
A practical approach is to review major giving decisions annually or when there are clear shifts in either personal values or the external evidence. Organisations like GiveWell typically update their recommendations and cost-effectiveness analyses each year, providing natural checkpoints.
References
- Newborns: reducing mortality — World Health Organization. 2022-01-17. https://www.who.int/news-room/fact-sheets/detail/newborns-reducing-mortality
- Elie Hassenfeld on two big-picture critiques of GiveWell’s approach, and six lessons from their recent work — 80,000 Hours Podcast. 2023-06-08. https://80000hours.org/podcast/episodes/elie-hassenfeld-givewell-critiques-and-lessons/
- Global Health Estimates: Life expectancy and leading causes of death and disability — World Health Organization. 2020-12-09. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates
- Elie Hassenfeld on two big picture critiques of GiveWell’s approach, and six lessons from their recent work — Evidence Action (newsroom summary). 2023-06-15. https://www.evidenceaction.org/newsroom/elie-hassenfeld-on-two-big-picture-critiques-of-givewells-approach-and-six-lessons-from-their-recent-work
- Poverty & Shared Prosperity 2022: Correcting Course — World Bank Group. 2022-10-05. https://www.worldbank.org/en/publication/poverty-and-shared-prosperity
- World Development Report 2008: Agriculture for Development — World Bank. 2007-10-19. https://openknowledge.worldbank.org/entities/publication/4c76fc7e-f7b3-5e82-bd41-bf1bfe24ac90
- HLI’s work is discussed on the 80k podcast: some comments — Happier Lives Institute. 2023-06-21. https://www.happierlivesinstitute.org/report/response-to-the-june-2023-80k-podcast-with-elie-hassenfeld/
